BJA Harold Rogers PDMP National Meeting on Data Driven Multi-Disciplinary Approaches to Reducing Rx Abuse
|
|
- Wilfrid Reynolds
- 6 years ago
- Views:
Transcription
1
2 SAMHSA Programs to Address Prescription Drug Misuse and Abuse Jinhee Lee, PharmD Division of Pharmacologic Therapies Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration BJA Harold Rogers PDMP National Meeting on Data Driven Multi-Disciplinary Approaches to Reducing Rx Abuse February 26, 2015
3 As we work to reduce substance abuse and the great damage it causes in our communities, we will make our country stronger and our people healthier and safer. President Barack Obama 3
4 SAMHSA s Programs Align with National Strategies & Fills Gaps SAMHSA s programs align with national strategies and metrics; are designed to complement the efforts of stakeholders and partners; and are intended to fill gaps in national, state, and local efforts. 4
5 Substance Abuse Prevention and Treatment Block Grants In 1981, Congress approved a new mechanism, the Block Grants (BG), as a way to provide assistance to States, Territories, and other local governing units that provide public MH/SUD services. BGs have an inherent flexibility so that individual localities can address the unique needs of their citizenry. This flexibility is balanced with statutory spending and reporting requirements designed to ensure public accountability, transparency, and return-oninvestment. 5
6 SABG Targeted Populations and Service Areas Pregnant women and women with dependent children Intravenous drug users Tuberculosis services Early intervention services for HIV/AIDS Primary prevention services 6
7 SAMHSA Block Grant Applications Two types of BGs are administered by SAMHSA: SABG MHBG Block Grant Applications are tripartite: 1) Behavioral Health Assessment & Plan ( Plan ) 2) BG Report 3) Synar Report A BG application is considered complete and fundable only after all 3 parts of the application have been submitted & approved. 7
8 SABG Block Grant Applications Submission options: Submit a separate SABG Plan Submit a single, combined SABG/MHBG Plan Combined submission maintains the integrity of the 2 different BGs, but streamlines the application process for states. For FY2012/2013 plans, 22 states and 2 jurisdictions submitted combined SABG/MHBG Plans. 8
9 SABG Application Timeline Behavioral Health Assessment & Plans are submitted biennially. SABG Reports are submitted annually. Synar Reports are submitted annually. Applications for SABG funds are submitted annually. The request for FY2015 funds is a separate, miniapplication (i.e., funding agreements & certifications; planned expenditures; & 2 planned expenditures checklists). 9
10 Strategic Prevention Framework Partnerships for Success State and Tribal Initiative The SPF-PFS program is designed to address one or both of the following substance abuse prevention priorities underage drinking among persons aged 12 to 20; a prescription drug misuse and abuse among persons aged 12 to 25. At their discretion, states/tribes may also use SPF- PFS funds to target an additional, data-driven prevention priority (e.g., marijuana, heroin) in their state/tribe. Slide 10
11 SPF-PFS Grantee Expectations Grantees are expected to work with their State/Tribal Epidemiological Outcome Workgroups (SEOWs) to identify their selected sub-recipient communities, document their identified needs and prevention priority(ies), and identify why these communities were selected over other high-need communities in the state/tribe. Grantees expected to explain how they will leverage, redirect, and/or realign prevention funds and resources (including SABG) to support SPF-PFS goals Slide 11
12 SPF-PFS Award Information RFA Number: SP Application Due Date: Friday, 3/16/2015 Anticipated Total Available Funding:$28 million Anticipated Number of Awards: up to 38 Anticipated Award Amount: From $318,543 to $2,472,608 per year Length of Project: Up to 5 years Program Contact Person: Tonia Gray at tonia.gray@samhsa.hhs.gov Website: Slide 12
13 Drug-Free Communities Support Program The DFC Program was created by the Drug-Free Communities Act of 1997 (Public Law ). The DFC Support Program has two goals: Establish and strengthen collaboration among communities, public and private non-profit agencies; as well as federal, state, local, and tribal governments to support the efforts of community coalitions working to prevent and reduce substance use among youth*. Reduce substance use among youth and, over time, reduce substance abuse among adults by addressing the factors in a community that increase the risk of substance abuse and promoting the factors that minimize the risk of substance abuse. *For the purposes of this RFA, youth is defined as individuals 18 years of age and younger. Slide 13
14 Drug-Free Communities Support RFA Number: SP Program Application Due Date: Wednesday, 3/18/2015 Anticipated Total Available Funding:$21, 250,000 Anticipated Number of Awards: ~ 170 Anticipated Award Amount: Up to $125,000 per year Length of Project: Up to 5 years Program Contact Person: Virginia Simmons at virginia.simmons@samhsa.hhs.gov Website: Slide 14
15 Grants to Expand Substance Abuse Treatment Capacity in Adult and Family Drug Courts Purpose: To expand and/or enhance substance abuse treatment services in existing adult and family problem solving courts, which use the treatment drug court model in order to provide alcohol and drug treatment to defendants/offenders. Application Due Date: Friday, March 27, 2015 RFA Number: TI , Anticipated Total Available Funding: $11,300,000 Anticipated Number of Awards: Up to 35 Anticipated Award Amount: Up to $325,000 Length of Project: Up to 3 years Contact Person: Gregory Torain at Gregory.torain@samhsa.hhs.gov Slide 15
16 SAMHSA Treatment Drug Courts Grant Expectations Grantees will be expected to provide a coordinated, multisystem approach designed to combine the sanctioning power of treatment drug courts with effective treatment services to break the cycle of criminal behavior, child abuse and neglect, alcohol and/or drug use, and incarceration or other penalties. Grants funds must be used to serve people diagnosed with a substance use disorder as their primary condition, particularly high risk/high need populations diagnosed with substance dependence or addiction to alcohol/other drugs and identified as needing immediate treatment. Slide 16
17 SAMHSA Treatment Drug Courts Grant Expectations Grant funds must be used to address gaps in the continuum of treatment for those individuals in these drug courts who have substance abuse and/or co-occurring disorders treatment needs. Grant funds may be used to provide services for comorbid conditions, such as mental health problems, as long as expenditures remain consistent with the drug court model which is designed to serve individuals needing treatment for substance dependence or addiction to alcohol/other drugs. Grant funds may be used to provide services for co-morbid conditions, such as mental health problems, as long as expenditures remain consistent with the drug court model which is designed to serve individuals needing treatment for substance dependence or addiction to alcohol/other drugs Slide 17
18 Targeted Capacity Expansion: Medication Assisted Treatment Prescription Drug and Opioid Addiction Purpose: Expand access to MAT services for persons with opioid use disorder. Award Size: $11 million Anticipated Number of Awards: Up to 11 Anticipated Award Amount: Up to $1 million Length of Project: Up to 3 years RFA posting date: February 26, 2015 Application due date: May 8, 2015 SAMHSA contact: Dr. Anthony Campbell at tony.campbell@samhsa.hhs.gov 18
19 SAMHSA TCE-MAT Grant Expectations The purpose of this program is to provide funding to states to enhance/expand their treatment service systems to increase capacity and provide accessible, effective, comprehensive, coordinated care, and evidencebased MAT and recovery support services to individuals with opioid use disorders seeking or receiving MAT. As a result of this program, SAMHSA seeks to: 1) increase the number of individuals receiving MAT services with pharmacotherapies approved by the FDA for the treatment of opioid use disorders; 2) increase the number of individuals receiving integrated care; and 3) decrease illicit drug use at 6-months follow-up. Priority will be given to states that have not only demonstrated a high rate of primary treatment admissions for heroin and opioids per capita, but that have also demonstrated a dramatic increase in hospital admissions in recent years. For more information please go to Slide 19
20 CDC Prescription Drug Overdose Prevention for States Cooperative Agreement The purpose of this funding is to provide state health departments the guidance and resources they need to address the problematic opioid prescribing driving the prescription drug overdose epidemic. States receiving funding must address prescribing on multiple fronts. Awardees must expand and enhance their state PDMP and implement health insurer or health system interventions. States may also choose to conduct policy evaluations or implement other prescribing innovations. Slide 20
21 CDC Prescription Drug Overdose Prevention for States Cooperative Agreement Estimated Post Date: Early March 2015 Estimated Application Due Date: Early May Estimated Funding: $55,600,000 Estimated Award Ceiling: $1,000,000 Estimated Award Floor: $750,000 dex.cfm?switch=grant.view&gff_grants_forec astinfoid= Slide 21
22 Thank you! Jinhee Lee, PharmD The findings and conclusions in this report are those of the author and do not necessarily represent the views of the Substance Abuse and Mental Health Services Administration. Slide 22
23
Wednesday, June 21, Dear Chairmen and Ranking Members:
The Honorable Rodney Frelinghuysen Committee on Appropriations 2306 Rayburn House Office Building The Honorable Tom Cole Subcommittee on Labor, Health and Human Services, Education and Related Agencies
More informationSuccessful Prevention Strategies to Address the Opioid Crises
Successful Prevention Strategies to Address the Opioid Crises Shannon Breitzman, MSW, Principal Denver Office Lindsey Kato, MPH, CHES, Consultant Denver Office 1 LEARNING OBJECTIVES + Find out how to effectively
More informationThe National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations
The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations March 2018 Update On March 23 rd, 2018, President Donald Trump signed a fiscal year 2018 (October 1,
More informationThe National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations
The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 November 2017 Update On May 23 rd, 2017 the Administration released its budget proposal for fiscal year (FY) 2018. On
More informationData-Driven Prevention Initiative
Data-Driven Prevention Initiative Arturo Brito, MD,MPH Deputy Commissioner New Jersey Department of Health Pain, Pain Management & Opioid Epidemic Symposium Princeton, New Jersey December 2, 2016 Reducing
More informationSAMHSA FY 2017 Discretionary Grant Forecast
SAMHSA FY 2017 Discretionary Grant Forecast Center FOA Title Purpose # of Garrett Lee Smith (GLS) Campus Suicide Prevention Grant The purpose of this program is to facilitate a comprehensive public health
More informationPDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health
PDMP Track: Linking and Mapping PDMP Data Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health Disclosure Statement Gillian Leichtling and Chris Baumgartner have disclosed no
More informationCollaborative for Effective Prescription Opioid Policies
The Honorable Richard Shelby Committee on Appropriations 304 Senate Office Building The Honorable Roy Blunt Subcommittee on Labor, Health and Human Services, Education and Related Agencies 260 Russell
More informationWashington State PMP Data Mapping Project
Washington State PMP Data Mapping Project 2014 Category 3 Grant Harold Rogers Category 3 Grantee Meeting February 25, 2015 Washington State BACKGROUND: OPIOID ISSUES AND PLANNING 2 WA Unintentional Opioid
More informationPublic Health Federal Funding Request to Address the Opioid Epidemic
Public Health Federal Funding Request to Address the Opioid Epidemic On December 4, 2017, in response to the President s recent declaration of the opioid epidemic as a public health emergency and the final
More informationKansas Department of Health and Environment (KDHE) Kansas Data-Driven Prevention Initiative Request for Proposal (RFP) Fiscal Year 2019
Kansas Department of Health and Environment (KDHE) Kansas Data-Driven Prevention Initiative Request for Proposal (RFP) Fiscal Year 2019 Kansas Department of Health and Environment Bureau of Health Promotion
More informationOps-Watch Weekly Grant Opportunities Update March 26 April 1, 2016
Ops-Watch Weekly Grant Opportunities Update March 26 April 1, 2016 Department of Commerce - National Institute of Standards and Technology - National Strategy for Trusted Identities in Cyberspace (NSTIC)
More informationVanila M Singh, MD MACM Chief Medical Officer Office of the Assistant Secretary for Health U.S. Department of Health and Human Services
Vanila M Singh, MD MACM Chief Medical Officer Office of the Assistant Secretary for Health U.S. Department of Health and Human Services 1 Summit Objectives Engage subject matter experts and key federal,
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationCDC s Approach to Addressing the Opioid Overdose Epidemic
CDC s Approach to Addressing the Opioid Overdose Epidemic Sarah Bacon National Center for Injury Prevention and Control Division of Unintentional Injury Prevention June 23, 2016 500,000 drug overdose deaths
More informationAssessing Opioid Misuse and Overdose Using Prescription Drug Monitoring Programs (PDMP) and Other Data Sources
Assessing Opioid Misuse and Overdose Using Prescription Drug Monitoring Programs (PDMP) and Other Data Sources NPN Conference Anaheim, CA September 12, 2017 Presentations Overview of SAMHSA s Prevention
More informationNational Strategies for Local Solutions
National Strategies for Local Solutions LCDR Michael R. Muni, MPA, MPH National Heroin Task Force Education and Community Awareness Committee s Staff Lead Substance Abuse Mental Health Services Administration
More informationThe National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2019 Budget and Appropriations
The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2019 Budget and August 2018 Update In February 2018, the Administration released its proposed budget for FY 2019 (October
More informationSeptember 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201
September 1, 2017 The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 Dear Secretary Price: The National Association of County
More informationPartnerships for Success Grant Overview, Timelines and Questions
Partnerships for Success Grant Overview, Timelines and Questions DBHR All Providers Meeting October 20, 2013 Yakima, WA Washington State of Social & Health Services Division of Behavioral Health and Recovery
More informationData-Driven Multidisciplinary Approaches to Reduce Prescription Drug Abuse in Kentucky
Data-Driven Multidisciplinary Approaches to Reduce Prescription Drug Abuse in Kentucky http://uknow.uky.edu/content/kentucky-awarded-grant-prescription-drugabuse-prevention-program Data-Driven Multidisciplinary
More informationSAMHSA FY 2016 Discretionary Grant Forecast
SAMHSA FY 2016 Discretionary Grant Forecast **Note: Programs listed as Budget Dependent will not be posted until more information is known about a final 2016 appropriation. All other announcements are
More informationThe Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country
Integrating Primary and Behavioral Health Care Through the Lens of Prevention July 14, 2016 New Orleans, Louisiana The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin
More informationOpportunities and Challenges for Nursing in WA State Medicaid Expansion and other New Initiatives. Session 2
Opportunities and Challenges for Nursing in WA State Medicaid Expansion and other New Initiatives Session 2 1 Learning Objectives Learn about WA State strategies for addressing the opioid crisis, including
More informationCoalition Strategies Across The Continuum of Care
Coalition Strategies Across The Continuum of Care Dorothy J. Chaney M.Ed. CADCA Consultant Building Safe, Healthy, and Drug Free Communities Overview and Objectives: By completing this training participants
More informationFrom Medicaid Transformation Approved Project Toolkit, June 2017
From Medicaid Transformation Approved Project Toolkit, June 2017 Domain 3: Prevention and Health Promotion Transformation projects within this domain focus on prevention and health promotion to eliminate
More informationHHSC LAR Request. Substance Abuse Disorder Coalition. Contact Person: Will Francis Members:
HHSC LAR Request Substance Abuse Disorder Coalition Contact Person: Will Francis wfrancis.naswtx@socialworkers.org Members: NAMI Texas Children s Defense Fund Texas Communities for Recovery National Association
More informationFDA s Response to the Opioid Crisis and the FDA Safe Use Initiative
FDA s Response to the Opioid Crisis and the FDA Safe Use Initiative Scott K. Winiecki, MD Professional Affairs and Stakeholder Engagement Staff (PASES) Center For Drug Evaluation and Research (CDER) U.S.
More informationTom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services
Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services Helping People Live Better Lives Background DHHS dynamic agency Helping
More informationOpioid Response Package Awaits President s Signature Trinity Tomsic
Issue Brief 18-38, October 19, 2018 Opioid Response Package Awaits President s Signature Trinity Tomsic 202-624-8577 ttomsic@ffis.org Summary Congress passed the SUPPORT for Patients and Communities Act
More information1025 Connecticut Avenue NW, Suite 605 * Washington, DC * (202) * Fax: (202)
Comprehensive Addiction and Recovery Act of 2014, S. 2839: A Section-by-Section Analysis Sponsored by Sen. Whitehouse (D-RI), Sen. Portman (R-OH), Sen. Klobuchar (D-MN), Sen. Ayotte (R-NH), and Sen. Leahy
More informationPerformance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)
Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and
More informationMeth and Opioid Abuse Prevention Efforts
Meth and Opioid Abuse Prevention Efforts Prescription Drugs/Opioids in South Dakota Departments of Health and Social Services Drug Abuse in South Dakota South Dakota ranked 2 nd lowest in the nation for
More informationComprehensive Substance Abuse Strategic Action Plan
Report on West Virginia s Comprehensive Substance Abuse Strategic Action Plan SubStance abuse is destroying West Virginia. People throughout the state, from the Northern Panhandle to the southern coalfields,
More informationBuilding a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine
Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Scott M. Gagnon, MPP, PS-C Director, AdCare Educational Institute of Maine, Inc. Co-Chair, Prevention & Harm
More informationWhatcom County. Opioid Abuse. Prevention & Response Plan
Whatcom County Opioid Abuse Prevention & Response Plan Prepared by the Whatcom County Health Department on Behalf of Whatcom has HOPE March 2017 INTRODUCTION On September 6, 2016, twenty-seven stakeholders
More informationStrategies for Federal Agencies
Confronting Pain Management and the Opioid Epidemic Strategies for Federal Agencies Over the past 25 years, the United States has experienced a dramatic increase in deaths from opioid overdose, opioid
More informationASTHO President s Challenge 15 x 15: Reduce Prescription Drug
ASTHO President s Challenge 15 x 15: Reduce Prescription Drug Misuse and Deaths 15% by 2015 Terry Cline, Ph.D. Commissioner of Health Oklahoma Secretary of Health and Human Services Prescription drugs
More informationSAMHSA Partnerships for Success Evaluation Plan Checklist
SAMHSA Partnerships for Success Evaluation Plan Checklist This checklist serves multiple purposes: (1) It provides guidelines for developing a well-rounded evaluation plan; (2) it specifies evaluation
More informationOpioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative
Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division
More informationBJA Peer Recovery Support Services Mentor Initiative: Mentor Application
BJA Peer Recovery Support Services Mentor Initiative: Mentor Application While there is no current data on opioid addiction among criminal justice involved individuals, it is estimated that two-thirds
More informationCommunity Engagement to Address the Opioid Crisis. Laura Palombi, PharmD, MPH, MAT, AE-C
Community Engagement to Address the Opioid Crisis Laura Palombi, PharmD, MPH, MAT, AE-C Presenter Information Assistant Professor at the University of Minnesota College of Pharmacy Affiliate Assistant
More informationFACT SHEET: Federal Parity Task Force Takes Steps to Strengthen Insurance Coverage for Mental Health and Substance Use Disorders
The White House Office of the Press Secretary For Immediate Release October 27, 2016 FACT SHEET: Federal Parity Task Force Takes Steps to Strengthen Insurance Coverage for Mental Health and Substance Use
More informationThe National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations
The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 August 2017 Update On May 23 rd, 2017 President Trump released America First: A Budget Blueprint to Make America Great
More informationBERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County
BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County NMPHA Annual Conference April 2, 2014 Marsha McMurray-Avila Coordinator, Bernalillo County Community
More informationOPIOID WORKGROUP LEADERSHIP TEAM
OPIOID WORKGROUP LEADERSHIP TEAM Community-wide Action Plan and Call to Action This brief summary of the Opioid Action Plan presented to the Skagit County Board of Health on December 13, 2016 provides
More informationCTAS FY 2018: Funding Opportunities for Healing to Wellness Courts February 6, 2018
CTAS FY 2018: Funding Opportunities for Healing to Wellness Courts February 6, 2018 Tribal Law and Policy Institute 8235 Santa Monica Blvd. Ste. 211 West Hollywood, CA 90046 www.home.tlpi.org www.wellnesscourts.org
More informationOPIOID INITIATIVE SMART GOALS AND OBJECTIVES Four Pillar Approach
OPIOID INITIATIVE SMART GOALS AND OBJECTIVES 2016-2019 Four Pillar Approach SMART OBJECTIVES Prevention focuses on practical strategies that prevent drug abuse before it even begins on a community level
More informationRX Drug Abuse Prevention in Nevada
Brian Sandoval Governor Richard Whitley Director State of Nevada Department of Health and Human Services Division Name RX Drug Abuse Prevention in Nevada Marco Erickson Health Program Manager II 8/29/2018
More informationPrescription Drug Abuse & Misuse: Neurobiology, Epidemiology, & EBPs
Prescription Drug Abuse & Misuse: Neurobiology, Epidemiology, & EBPs H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM Director Center for Substance Abuse Treatment Substance Abuse Mental Health Services
More informationNCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Medicaid Transformation Project
NCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Introduction The North Central Accountable Community of Health (NCACH) is accepting applications from partners
More informationAssociation of State and Territorial Health Officials (ASTHO)
Association of State and Territorial Health Officials (ASTHO) Strategy Session on Prescription Drug Misuse and Abuse Prepared by: August 13-14, 2013 Table of Contents Introduction... 1 Setting Future Direction
More informationSEOW Annual Report. Presented to SPF PFS Management. Report Timeframe: October 2015 September 2016
SEOW Annual Report Presented to SPF PFS Management Report Timeframe: October 2015 September 2016 Alignment of DE SEOW with SAMHSA Identified Core Tasks The Delaware State Epidemiological Outcomes Workgroup
More informationMichael M. Miller, MD, FASAM, FAPA
Michael M. Miller, MD, FASAM, FAPA mmiller@rogershospital.org Medical Director, Herrington Recovery Center (HRC) Rogers Memorial Hospital Oconomowoc, Wisconsin Vice Speaker Wisconsin Medical Society Clinical
More informationOPIOIDS IN AMERICA. A complex crisis. A comprehensive response.
OPIOIDS IN AMERICA A complex crisis. A comprehensive response. Prescription opioids play a critical role in helping millions of people effectively manage chronic pain. But for some, opioid use has become
More information20% A Holistic Approach Built on Evidence OF U.S. ADULTS EXPERIENCE MENTAL ILLNESS EACH YEAR
BEHAVIORAL HEALTH NEARLY 20% OF U.S. ADULTS EXPERIENCE MENTAL ILLNESS EACH YEAR Source: SAMHSA, 2018. Key substance use and mental health indicators in the United States: Results from the 2017 National
More informationSAMHSA: A Public Health Agency
SAMHSA: A Public Health Agency Mission: To reduce the impact of substance abuse and mental illness on America s communities. Vision: SAMHSA provides leadership and devotes its resources towards helping
More informationImplementation of a Community-Wide Screening and Brief Intervention Project
Implementation of a Community-Wide Screening and Brief Intervention Project When you look at what determines morbidity in this country, 80% of that has nothing to do with the quality of health care received
More informationImplementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse
Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Jay Butler, MD, President of ASTHO, Chief Medical Officer, Alaska Department of Health
More informationSUMMIT ON REDUCING THE SUPPLY OF ILLEGAL OPIOIDS IN WASHINGTON. Legislative Action: Opportunities and Challenges June 16, 2017
SUMMIT ON REDUCING THE SUPPLY OF ILLEGAL OPIOIDS IN WASHINGTON Legislative Action: Opportunities and Challenges June 16, 2017 Session Objectives Learn about laws adopted in other states to curtail the
More informationQUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
More informationThe Opioid Addiction Crisis in the Northern Shenandoah Valley. A Community Response
The Opioid Addiction Crisis in the Northern Shenandoah Valley A Community Response 1 Overview of the Problem Objectives Formation of the Northern Shenandoah Valley Substance Abuse Coalition Roles of key
More informationSteve Daviss MD DFAPA Senior Medical Advisor Office of the Chief Medical Officer
Steve Daviss MD DFAPA Senior Medical Advisor Office of the Chief Medical Officer steve.daviss@samhsa.hhs.gov Disclaimer: Comments are my own and do not necessarily reflect the position or policy of SAMHSA
More informationKansas Prescription Drug and Opioid Advisory Committee
Kansas Prescription Drug and Opioid Advisory Committee Vision: To build capacity, mobilize resources, and enhance the quality and availability of data to support data-driven strategic planning at the state
More informationTri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary
Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon 2016 Executive Summary 20.8 million people in the United States have a substance use disorder (not limited to opioids), equivalent
More informationProgram Evaluation for Prevention: Partnerships for Success
Program Evaluation for Prevention: Partnerships for Success Final Evaluation Report September 2018 DEPARTMENT OF HEALTH & HUMAN SERVICES USA U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse
More informationState Action to Prevent and
State Action to Prevent and Treat Prescription Drug Abuse Paul Jarris, MD, MBA Executive Director Association of State and Territorial Health Officials Hearing from Each Other: State Reports NGA Policy
More informationNIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse
NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Virtually All of the U.S. Have Increased Drug Overdoses:
More informationNational Viral Hepatitis Action Plan Priority Populations Approach
National Viral Hepatitis Action Plan Priority Populations Approach November 29, 2017 Corinna Dan, RN, MPH Office of HIV/AIDS and Infectious Disease Policy Office of the Assistant Secretary for Health Department
More informationBrockton Area Opioid Abuse Prevention Collaborative. Quick Guide
Brockton Area Opioid Abuse Prevention Collaborative Quick Guide Brockton Area Opioid Abuse Prevention Collaborative 30 Meadowbrook Road Brockton, MA 02301 508-742-4490 Staff: Hillary Dubois, Director Amanda
More informationNational Comprehensive Cancer Control Program Reviewer Training March 16, 2017
FOA DP17-1701 Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations National Comprehensive Cancer Control Program Reviewer Training March 16, 2017 Angela Moore, MPH, Team
More informationSAMHSA/HHS: An Update on the Opioid Crisis
SAMHSA/HHS: An Update on the Opioid Crisis Elinore F. McCance-Katz, MD, PhD Assistant Secretary for Mental Health and Substance Use Substance Abuse and Mental Health Services Administration U.S. Department
More informationAddressing Substance Use Disorder and the Opioid Epidemic in North Carolina
1 Addressing Substance Use Disorder and the Opioid Epidemic in North Carolina This document describes the purpose of Blue Cross and Blue Shield of North Carolina s Addressing Substance Use Disorder and
More informationPreventing Opioid Misuse in Texas
Preventing Opioid Misuse in Texas Kasey Strey, ACPS, SPF-Rx Project Director Jessica Duncan Cance, MPH, PhD, TTOR Lead Purpose Provide an overview of HHSC -funded opioid misuse prevention activities Discuss
More informationPrescription Opioid Overdose in Oregon: A public health perspective
Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,
More informationCOMMUNITY ASSESSMENT OF THE OPIOID CRISIS IN LORAIN COUNTY, OHIO EXECUTIVE SUMMARY
COMMUNITY ASSESSMENT OF THE OPIOID CRISIS IN LORAIN COUNTY, OHIO Prepared for The Nord Family Foundation December 20, 2017 Background The impact of the opioid crisis in Lorain County, Ohio is far-reaching
More informationSeptember 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic
National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC 20036 RE: Prescription Opioid Epidemic On behalf of America s Health Insurance Plans (AHIP), thank you for your leadership
More informationBob Flewelling, PIRE Amy Livingston, PIRE Claudia Marieb, Vermont Dept. of Health Melanie Sheehan, Mt. Ascutney Hospital and Health Center
Community-Based Approaches to Reducing Underage Drinking and R x Drug Misuse: Encouraging Findings and Lessons Learned from Vermont s Partnerships for Success (PFS) II Project Bob Flewelling, PIRE Amy
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2385/18 25 April 2018 Original: English THE OPIOID
More informationHarold Rogers Update Melissa McPheeters, PhD, MPH
Harold Rogers Update 2017 Melissa McPheeters, PhD, MPH We Need a New Normal Full collaboration among diverse departments Appropriate integration of data from disparate data sources Business intelligence
More informationOpioid Crisis: HHS Strategy and Advancing Pain Management
OFFICE OF THE Opioid Crisis: HHS Strategy and Advancing Pain Management Rachel Katonak, PhD, RN LCDR, Nurse Officer U.S. Public Health Service Public Health Analyst U.S. Department of Health and Human
More informationBrockton Area Prevention Collaborative 30 Meadowbrook Road Brockton, MA
Brockton Area Prevention Collaborative 30 Meadowbrook Road Brockton, MA 02301 508-742-4490 Staff: Hillary Dubois, Director Amanda Sandoval, Assistant Director Anna Dowd, Coalition Coordinator Kelly Macomber,
More informationHouse Committee on Energy and Commerce House Committee on Energy and Commerce. Washington, DC Washington, DC 20515
February 28, 2018 The Honorable Michael Burgess, M.D. The Honorable Gene Green Chairman Ranking Member Subcommittee on Health Subcommittee on Health House Committee on Energy and Commerce House Committee
More informationAmerican Academy of Pain Medicine American Pain Society American Society of Anesthesiologists
PAIN CARE COALITION A National Coalition for Responsible Pain Care American Academy of Pain Medicine American Pain Society American Society of Anesthesiologists August 29, 2017 The Honorable Chris Christie,
More informationTaos Alive. Improving a Community in Pain By Julie Martinez CPS
Taos Alive Improving a Community in Pain By Julie Martinez CPS About Taos County About Taos Alive Community Based Coalition 12 Sectors (Youth, Parents, Business, Media, Schools, Youth Serving Organizations,
More informationPrescription Drug Abuse National Perspective
Prescription Drug Abuse National Perspective Timothy P. Condon, Ph.D. Science Policy Advisor Office of the Director White House Office of National Drug Control Policy Commonly Abused Prescription Drugs
More informationThe Opioid Crisis Made in America Fade in America?
The Opioid Crisis Made in America Fade in America? The President s Commission On Combating Drug Addiction and the Opioid Crisis Bertha K Madras, PhD Professor of Psychobiology Department of Psychiatry
More informationSUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT ALLOCATION PLAN FEDERAL FISCAL YEAR 2012
DEPARTMENT OF MENTAL HEALTH AND ADDICTION SERVICES SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT ALLOCATION PLAN FEDERAL FISCAL YEAR 2012 August 2011 STATE OF CONNECTICUT SUBSTANCE ABUSE PREVENTION
More informationPDSA Delaware: A Data and Logic Model Driven Prescription Drug and Substance Abuse Change Approach for Delaware
PDSA Delaware: A Data and Logic Model Driven Prescription Drug and Substance Abuse Change Approach for Delaware Funded by BJA Harold Rogers Program FY2014 Award #2014-PM-BX-0002 February 25 th, 2015 Data-Driven
More informationHeather L. Clinger, MPH, CPS Cathy Sisco, MPA, CPS Sara Wakai, PhD. August 2018 National Prevention Network Annual Conference
Heather L. Clinger, MPH, CPS Cathy Sisco, MPA, CPS Sara Wakai, PhD August 2018 National Prevention Network Annual Conference How to Begin a Coalition Use the Strategic Prevention Framework (SPF) to guide
More informationOverdose Fatality Review
Overdose Fatality Review Erin Haas and Laura Bartolomei-Hill Department of Health and Mental Hygiene BJA Grantee meeting 3/30/2017 Overdose in Maryland What is Overdose Fatality Review? Modeled after
More informationOpportunities for Engaging Partners to Prevent Opioid Overdose-related Deaths
PREVENTION COLLABORATION IN ACTION Engaging the Right Partners Opportunities for Engaging Partners to Prevent Opioid Overdoserelated Deaths Preventing opioid overdose requires collaboration with a diverse
More informationADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians
ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of
More informationBehavioral Health Indicators Workgroup: Overview
Behavioral Health Indicators Workgroup: Overview Rationale Mental health and substance abuse disorders among children, youth, and young adults are major threats to the health and well-being of younger
More informationThe National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2019 Appropriations
The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2019 Appropriations February 2019 Update On September 28, 2018, President Trump signed into law a bill that funds some federal
More informationMoving Towards a Continuum of Services. Plumas County Alcohol & Drug Strategic Planning Process DRAFT PLAN
Moving Towards a Continuum of Services Plumas County Alcohol & Drug Strategic Planning Process DRAFT PLAN Summary Substance use, abuse and addiction range in intensity from experimentation to severe and
More information2/20/2019. Source: Source:
The misuse of and addiction to opioids including prescription pain relievers, heroin, and synthetic opioids such as fentanyl is a serious national crisis that affects public health as well as social and
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE September 20, 2013 Association of State and Territorial Health Officials Annual Meeting R. Gil Kerlikowske Director of National Drug Control Policy National
More informationEXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS
EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS Gina M. Raimondo, Governor Nicole Alexander-Scott, MD, MPH, Director of Health Action Plan Strategies to Date Since 2015, we
More informationOpioid Task Force Kick-Off Meeting. February 29, 2016
Opioid Task Force Kick-Off Meeting February 29, 2016 Scope of the Opioid Problem and Data Review Olivia Kasirye, MD, MS County Public Health Officer OVERVIEW The Opioid Epidemic Opioid Task Force Development
More information